Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila A Doggrell

Showing results (11-20 of 220) with videos related to

Pageof 22
Sort By:
Expert Opinion on Pharmacotherapy|June 15, 2005
Recent important trials of pharmacotherapy in Parkinson's diseaseSheila A Doggrell
Expert Opinion on Pharmacotherapy|June 7, 2005
Which drug combination for hormone-refractory prostate cancer?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|July 25, 2006
After the failure of citalopram for depression, what next?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|April 2, 2008
The failure of torcetrapib: is there a case for independent preclinical and clinical testing?Sheila A Doggrell
Reviews on Recent Clinical Trials|May 14, 2008
Is exenatide improving the treatment of type 2 diabetes? Analysis of the individual clinical trials with exenatideSheila A Doggrell
Expert Opinion on Pharmacotherapy|December 24, 2005
Is exenatide advancing the treatment of type 2 diabetes?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|November 7, 2009
Good clinical endpoints with denosumab in osteoporosis and cancerSheila A Doggrell
Expert Opinion on Pharmacotherapy|March 3, 2018
Cardiovascular outcomes trial with anacetrapib in subjects with high cardiovascular risk - are major benefits REVEALed?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|June 27, 2002
Zoledronate once-yearly increases bone mineral density--implications for osteoporosisSheila A Doggrell
Expert Opinion on Pharmacotherapy|January 29, 2008
Clinical trials with thiazolidinediones in subjects with Type 2 diabetes--is pioglitazone any different from rosiglitazone?Sheila A Doggrell
Pageof 22

Showing results (11-20 of 220) with videos related to

Sort By:
Pageof 22
Expert Opinion on Pharmacotherapy|June 15, 2005
Recent important trials of pharmacotherapy in Parkinson's diseaseSheila A Doggrell
Expert Opinion on Pharmacotherapy|June 7, 2005
Which drug combination for hormone-refractory prostate cancer?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|July 25, 2006
After the failure of citalopram for depression, what next?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|April 2, 2008
The failure of torcetrapib: is there a case for independent preclinical and clinical testing?Sheila A Doggrell
Reviews on Recent Clinical Trials|May 14, 2008
Is exenatide improving the treatment of type 2 diabetes? Analysis of the individual clinical trials with exenatideSheila A Doggrell
Expert Opinion on Pharmacotherapy|December 24, 2005
Is exenatide advancing the treatment of type 2 diabetes?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|November 7, 2009
Good clinical endpoints with denosumab in osteoporosis and cancerSheila A Doggrell
Expert Opinion on Pharmacotherapy|March 3, 2018
Cardiovascular outcomes trial with anacetrapib in subjects with high cardiovascular risk - are major benefits REVEALed?Sheila A Doggrell
Expert Opinion on Pharmacotherapy|June 27, 2002
Zoledronate once-yearly increases bone mineral density--implications for osteoporosisSheila A Doggrell
Expert Opinion on Pharmacotherapy|January 29, 2008
Clinical trials with thiazolidinediones in subjects with Type 2 diabetes--is pioglitazone any different from rosiglitazone?Sheila A Doggrell
Pageof 22